Series B - New Haven Pharmaceuticals - Oct 23, 2014 Funding Round Profile - Cointime

Bitcoin $95,331.70 -2.44%
Ethereum $3,350.75 -1.97%
BNB $695.21 -1.75%
Optimism $1.79 -2.84%
Arbitrum $0.76 -1.57%
Solana $187.81 -2.89%
Polygon $0.48 -2.25%
Cosmos $6.52 -2.18%
Avalanche $37.32 -3.65%

Bitcoin $95,331.70 -2.44%
Ethereum $3,350.75 -1.97%
BNB $695.21 -1.75%
Optimism $1.79 -2.84%
Arbitrum $0.76 -1.57%
Solana $187.81 -2.89%
Polygon $0.48 -2.25%
Cosmos $6.52 -2.18%
Avalanche $37.32 -3.65%

New Haven Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 11.78M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
EJ Funds	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 31, 2013	Debt Financing	0	Advantage Capital	Detail
Oct 29, 2012	Series A	$ 6.49M	Advantage Capital,EJ Funds	Detail
Sep 30, 2012	Series Unknown	0	Advantage Capital	Detail